Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × SCLC, Extensive Stage × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Breast Neoplasms 193 Carcinoma, Non-Small-Cell Lung 184 Prostatic Neoplasms 147 Multiple Myeloma 99 Neoplasms 89 Colorectal Neoplasms 89 Squamous Cell Carcinoma of Head and Neck 82 Leukemia, Myeloid, Acute 80 Neoplasm Metastasis 75 Lung Neoplasms 74 Melanoma 72 Pancreatic Neoplasms 64 Ovarian Neoplasms 61 Triple Negative Breast Neoplasms 57 Recurrence 56 Carcinoma, Hepatocellular 56 Leukemia, Lymphocytic, Chronic, B-Cell 53 Brain Neoplasms 52 Glioblastoma 49 Lymphoma 48 Carcinoma, Renal Cell 45 Urinary Bladder Neoplasms 42 Sarcoma 42 Endometrial Neoplasms 41 Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Lymphoma, Large B-Cell, Diffuse 37 Head and Neck Neoplasms 37 Stomach Neoplasms 36 Uterine Cervical Neoplasms 35 Rectal Neoplasms 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07321574 2026-01-07

ABP1011T-03

Shanghai AB PharmaTech Ltd.

Phase 2 Recruiting

Other solid neoplasmThoracic

SCLC, Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡